Logo image of CIZN

CITIZENS HOLDING COMPANY (CIZN) Stock Fundamental Analysis

NASDAQ:CIZN - Nasdaq - US1747151025 - Common Stock - Currency: USD

8.85  -0.69 (-7.23%)

After market: 9.6 +0.75 (+8.47%)

Fundamental Rating

2

Overall CIZN gets a fundamental rating of 2 out of 10. We evaluated CIZN against 402 industry peers in the Banks industry. CIZN has a bad profitability rating. Also its financial health evaluation is rather negative. CIZN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CIZN had positive earnings in the past year.
CIZN had a positive operating cash flow in the past year.
CIZN had positive earnings in each of the past 5 years.
Each year in the past 5 years CIZN had a positive operating cash flow.
CIZN Yearly Net Income VS EBIT VS OCF VS FCFCIZN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M

1.2 Ratios

CIZN has a worse Return On Assets (0.36%) than 91.59% of its industry peers.
Looking at the Return On Equity, with a value of 14.90%, CIZN belongs to the top of the industry, outperforming 83.17% of the companies in the same industry.
Industry RankSector Rank
ROA 0.36%
ROE 14.9%
ROIC N/A
ROA(3y)0.58%
ROA(5y)0.59%
ROE(3y)12.51%
ROE(5y)10.14%
ROIC(3y)N/A
ROIC(5y)N/A
CIZN Yearly ROA, ROE, ROICCIZN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 5 10 15 20

1.3 Margins

With a Profit Margin value of 12.20%, CIZN is not doing good in the industry: 89.18% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of CIZN has grown nicely.
The Operating Margin and Gross Margin are not available for CIZN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 12.2%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y8.01%
PM growth 5Y15.02%
GM growth 3YN/A
GM growth 5YN/A
CIZN Yearly Profit, Operating, Gross MarginsCIZN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 5 10 15 20

More info and screens

0

2. Health

2.1 Basic Checks

CIZN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CIZN remains at a similar level compared to 1 year ago.
CIZN has a worse debt/assets ratio than last year.
CIZN Yearly Shares OutstandingCIZN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M 4M 5M
CIZN Yearly Total Debt VS Total AssetsCIZN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B

2.2 Solvency

The Debt to FCF ratio of CIZN is 27.14, which is on the high side as it means it would take CIZN, 27.14 years of fcf income to pay off all of its debts.
CIZN's Debt to FCF ratio of 27.14 is on the low side compared to the rest of the industry. CIZN is outperformed by 86.30% of its industry peers.
A Debt/Equity ratio of 4.93 is on the high side and indicates that CIZN has dependencies on debt financing.
CIZN's Debt to Equity ratio of 4.93 is on the low side compared to the rest of the industry. CIZN is outperformed by 98.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.93
Debt/FCF 27.14
Altman-Z N/A
ROIC/WACCN/A
WACC6.06%
CIZN Yearly LT Debt VS Equity VS FCFCIZN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CIZN Yearly Current Assets VS Current LiabilitesCIZN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M

More info and screens

1

3. Growth

3.1 Past

CIZN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.77%.
CIZN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.06% yearly.
Looking at the last year, CIZN shows a decrease in Revenue. The Revenue has decreased by -8.40% in the last year.
The Revenue has been growing slightly by 5.25% on average over the past years.
EPS 1Y (TTM)-42.77%
EPS 3Y13.71%
EPS 5Y18.06%
EPS Q2Q%-52.17%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y8.98%
Revenue growth 5Y5.25%
Sales Q2Q%-10.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CIZN Yearly Revenue VS EstimatesCIZN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
CIZN Yearly EPS VS EstimatesCIZN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 0.5 1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.73, the valuation of CIZN can be described as reasonable.
CIZN's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 29.35. CIZN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.73
Fwd PE N/A
CIZN Price Earnings VS Forward Price EarningsCIZN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CIZN indicates a somewhat cheap valuation: CIZN is cheaper than 62.74% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.98
EV/EBITDA N/A
CIZN Per share dataCIZN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.54
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

CIZN has a Yearly Dividend Yield of 8.69%, which is a nice return.
CIZN's Dividend Yield is rather good when compared to the industry average which is at 3.37. CIZN pays more dividend than 99.04% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, CIZN pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.69%

5.2 History

The dividend of CIZN has a limited annual growth rate of 0.03%.
CIZN has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.03%
Div Incr Years0
Div Non Decr Years0
CIZN Yearly Dividends per shareCIZN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.2 0.4 0.6 0.8 1

5.3 Sustainability

87.87% of the earnings are spent on dividend by CIZN. This is not a sustainable payout ratio.
The dividend of CIZN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP87.87%
EPS Next 2YN/A
EPS Next 3YN/A
CIZN Yearly Income VS Free CF VS DividendCIZN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M
CIZN Dividend Payout.CIZN Dividend Payout, showing the Payout Ratio.CIZN Dividend Payout.PayoutRetained Earnings

More info and screens

CITIZENS HOLDING COMPANY

NASDAQ:CIZN (12/14/2023, 8:00:00 PM)

After market: 9.6 +0.75 (+8.47%)

8.85

-0.69 (-7.23%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-27 2023-10-27/bmo
Earnings (Next)01-22 2024-01-22/bmo
Inst Owners0.02%
Inst Owner Change-99.4%
Ins Owners11.21%
Ins Owner Change0%
Market Cap49.74M
Analysts43.33
Price TargetN/A
Short Float %0.41%
Short Ratio3.21
Dividend
Industry RankSector Rank
Dividend Yield 8.69%
Yearly Dividend0.96
Dividend Growth(5Y)0.03%
DP87.87%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.73
Fwd PE N/A
P/S 1.19
P/FCF 7.98
P/OCF 6.82
P/B 1.45
P/tB 2.38
EV/EBITDA N/A
EPS(TTM)0.91
EY10.28%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.11
FCFY12.53%
OCF(TTM)1.3
OCFY14.66%
SpS7.45
BVpS6.1
TBVpS3.72
PEG (NY)N/A
PEG (5Y)0.54
Profitability
Industry RankSector Rank
ROA 0.36%
ROE 14.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 12.2%
GM N/A
FCFM 14.88%
ROA(3y)0.58%
ROA(5y)0.59%
ROE(3y)12.51%
ROE(5y)10.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y8.01%
PM growth 5Y15.02%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 4.93
Debt/FCF 27.14
Debt/EBITDA N/A
Cap/Depr 82.81%
Cap/Sales 2.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 121.92%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC6.06%
ROIC/WACCN/A
Cap/Depr(3y)202.94%
Cap/Depr(5y)152.07%
Cap/Sales(3y)5.36%
Cap/Sales(5y)4%
Profit Quality(3y)162.61%
Profit Quality(5y)175.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-42.77%
EPS 3Y13.71%
EPS 5Y18.06%
EPS Q2Q%-52.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y8.98%
Revenue growth 5Y5.25%
Sales Q2Q%-10.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.39%
FCF growth 3Y-3.72%
FCF growth 5Y7.6%
OCF growth 1Y-61.04%
OCF growth 3Y0.64%
OCF growth 5Y5.32%